Current Assets
Total Current Assets
Neurocrine Biosciences Total Current Assets decreased by 3.4% to $2.44B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 48.7%, from $1.64B to $2.44B. Over 5 years (FY 2020 to FY 2025), Total Current Assets shows an upward trend with a 19.9% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
StatementBalance Sheet Statement
SectionCurrent Assets
CategoryLiquidity
SignalHigher is better
VolatilityStable
First reportedQ4 2014
Last reportedQ1 2026May 5, 2026
How to read this metric
Higher levels indicate stronger short-term liquidity, though excessive levels may suggest inefficient capital allocation.
Detailed definition
The sum of all assets that are expected to be converted into cash or consumed within one year. This provides a snapshot...
Peer comparison
Compared against current liabilities to determine the current ratio, a standard measure of short-term financial health.
Metric ID:
total_current_assetsHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.11B | $1.01B | $972.80M | $1.02B | $1.02B | $1.21B | $1.45B | $1.43B | $1.50B | $1.65B | $1.61B | $1.80B | $1.67B | $1.88B | $1.72B | $1.64B | $1.75B | $2.16B | $2.52B | $2.44B |
| QoQ Change | — | -9.4% | -3.3% | +4.7% | +0.1% | +18.3% | +20.6% | -1.4% | +4.5% | +10.2% | -2.6% | +11.9% | -7.2% | +12.4% | -8.1% | -5.0% | +6.8% | +23.4% | +16.9% | -3.4% |
| YoY Change | — | — | — | — | -8.2% | +19.9% | +49.4% | +40.7% | +46.8% | +36.9% | +10.6% | +25.6% | +11.6% | +13.7% | +7.3% | -9.0% | +4.7% | +15.0% | +46.3% | +48.7% |
Range$972.80M – $2.52B
CAGR+18.0%
Avg YoY Growth+22.5%
Median YoY Growth+17.4%
Total Current Assets at Other Companies
Frequently Asked Questions
- What is Neurocrine Biosciences's total current assets?
- Neurocrine Biosciences (NBIX) reported total current assets of $2.44B in Q1 2026.
- How has Neurocrine Biosciences's total current assets changed year-over-year?
- Neurocrine Biosciences's total current assets increased by 48.7% year-over-year, from $1.64B to $2.44B.
- What is the long-term trend for Neurocrine Biosciences's total current assets?
- Over 5 years (2020 to 2025), Neurocrine Biosciences's total current assets has grown at a 19.9% compound annual growth rate (CAGR), from $1.02B to $2.52B.
- What does total current assets mean?
- The total value of all assets that can be turned into cash within one year.